NHERF-2 maintains endothelial homeostasis

Blood

Volumn 119, Issue 20, 2012, Pages 4798-4806

  Bhattacharya, Resham ^a   Wang, Enfeng ^a   Dutta, Shamit K ^a   Vohra, Pawan K ^a   Guangqi, E ^a   Prakash, Y S ^a   Mukhopadhyay, Debabrata ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIN D1; MYC PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; GENE SILENCING; HEMANGIOMA; HOMEOSTASIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 84861208348     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-392563     Document Type: Article

References (47)

1. Kirton JP, Xu Q. Endothelial precursors in vascular repair. Microvasc Res. 2010;79(3):193-199.
2. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246(4935):1306-1309. (Pubitemid 20066716)
3. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219(4587):983-985.
4. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE. 2001;2001(112):re21.
5. Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem. 2001;276(29):26969-26979.
6. Soker S, Miao HQ, Nomi M, et al. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem. 2002;85(2):357-368. (Pubitemid 34274903)
7. Wang L, Zeng H, Wang P, et al. Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem. 2003;278(49):48848-48860.
8. Voltz JW, Weinman EJ, Shenolikar S. Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene. 2001;20(44):6309-6314. (Pubitemid 32977839)
9. Shenolikar S, Voltz JW, Cunningham R, et al. Regulation of ion transport by the NHERF family of PDZ proteins. Physiology (Bethesda). 2004;19:362-369. (Pubitemid 39636084)
10. Weinman EJ, Steplock D, Shenolikar S. CAMPmediated inhibition of the renal brush border membrane Na+-H+ exchanger requires a dissociable phosphoprotein cofactor. J Clin Invest. 1993;92(4):1781-1786. (Pubitemid 23304543)
11. Yun CH, Oh S, Zizak M, et al. cAMP-mediated inhibition of the epithelial brush border Na+/H+exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci U S A. 1997;94(7):3010-3015. (Pubitemid 27157255)
12. Chen M, Sultan A, Cinar A, et al. Loss of PDZadaptor protein NHERF2 affects membrane localization and cGMP- and [Ca2+]- but not cAMPdependent regulation of Na+/H+ exchanger 3 in murine intestine. J Physiol. 2010;588(Pt 24):5049-5063.
13. Alexander RT, Grinstein S. Tethering, recycling and activation of the epithelial sodium-proton exchanger, NHE3. J Exp Biol. 2009;212(Pt 11):1630-1637.
14. Rozengurt E. Early signals in the mitogenic response. Science. 1986;234(4773):161-166.
15. Putney LK, Barber DL. Na-H exchange-dependent increase in intracellular pH times G2/M entry and transition. J Biol Chem. 2003;278(45):44645-44649. (Pubitemid 37377220)
16. Weinman EJ, Hall RA, Friedman PA, et al. The association of NHERF adaptor proteins with g protein-coupled receptors and receptor tyrosine kinases. Annu Rev Physiol. 2006;68:491-505.
17. Theisen CS, Wahl JK, 3rd Johnson KR, et al. NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility. Mol Biol Cell. 2007;18(4):1220-1232. (Pubitemid 46626617)
18. Durr E, Yu J, Krasinska KM, et al. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol. 2004;22(8):985-992. (Pubitemid 39014475)
19. Bhattacharya R, Senbanerjee S, Lin Z, et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem. 2005;280(32):28848-28851. (Pubitemid 41161328)
20. Bhattacharya R, Nicoloso M, Arvizo R, et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009;69(23):9090-9095.
21. Bhattacharya R, Kwon J, Li X, et al. Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci. 2009;122(Pt 7):1025-1034.
22. Yochum GS, McWeeney S, Rajaraman V, et al. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proc Natl Acad Sci U S A. 2007;104(9):3324-3329. (Pubitemid 46364158)
23. Jensen MM, Jorgensen JT, Binderup T, et al. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-micro-PET or external caliper. BMC Med Imaging. 2008;8:16.
24. Wallgard E, Larsson E, He L, et al. Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler Thromb Vasc Biol. 2008;28(8):1469-1476.
25. Hoover ML, Vetvicka V, Hoffpauir JM, et al. Human endothelial cell line from an angiosarcoma. In Vitro Cell Dev Biol. 1993;29A(3 pt 1):199-202. (Pubitemid 23123706)
26. Unger RE, Krump-Konvalinkova V, Peters K, et al. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res. 2002;64(3):384-397. (Pubitemid 35370740)
27. Bhattacharya R, Kwon J, Wang E, et al. Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J Mol Signal. 2008;3:8.
28. Waltenberger J, Claesson-Welsh L, Siegbahn A, et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269(43):26988-26995. (Pubitemid 24332901)
29. Dejana E, Spagnuolo R, Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost. 2001;86(1):308-315. (Pubitemid 32663961)
30. Ha CH, Bennett AM, Jin ZG. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem. 2008;283(11):7261-7270.
31. Kalashnik L, Bridgeman CJ, King AR, et al. A cell kinetic analysis of human umbilical vein endothelial cells. Mech Ageing Dev. 2000;120(1-3):23-32.
32. Yang W, Shen J, Wu M, et al. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene. 2001;20(14):1688- 1702. (Pubitemid 32368016)
33. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13(12):1501-1512. (Pubitemid 29297917)
34. O'Hagan RC, Ohh M, David G, et al. Mycenhanced expression of Cul1 promotes ubiquitindependent proteolysis and cell cycle progression. Genes Dev. 2000;14(17):2185-2191.
35. Keller UB, Old JB, Dorsey FC, et al. Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. EMBO J. 2007;26(10):2562-2574. (Pubitemid 46788317)
36. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422-426. (Pubitemid 29180374)
37. Hulit J, Wang C, Li Z, et al. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol. 2004;24(17):7598-7611. (Pubitemid 39121486)
38. Williams RL, Risau W, Zerwes HG, et al. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell. 1989;57(6):1053-1063. (Pubitemid 19168385)
39. Grant JW, Gallagher PJ, Hedinger C. Haemangioblastoma. An immunohistochemical study of ten cases. Acta Neuropathol. 1988;76(1):82-86.
40. Hobson B, Denekamp J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer. 1984;49(4):405-413. (Pubitemid 14125248)
41. KrugerWA, Yun CC, Monteith GR, et al. Muscarinicinduced recruitment of plasma membrane Ca2+- ATPase involves PSD-95/Dlg/Zo-1-mediated interactions. J Biol Chem. 2009;284(3):1820-1830.
42. HammesA, Oberdorf S, Strehler EE, et al. Differentiation-specific isoform mRNA expression of the calmodulin-dependent plasma membrane Ca(2+)-ATPase. FASEB J. 1994;8(6):428-435.
43. DeMarco SJ, Chicka MC, Strehler EE. Plasma membrane Ca2+ATPase isoform 2b interacts preferentially with Na+/H+ exchanger regulatory factor 2 in apical plasma membranes. J Biol Chem. 2002;277(12):10506-10511. (Pubitemid 34968173)
44. Salehi Z, Niedel JE. Multiple calcium-mediated mechanisms regulate c-myc expression in HL-60 cells. J Immunol. 1990;145(1):276-282. (Pubitemid 20217412)
45. Perry BN, Govindarajan B, Bhandarkar SS, et al. Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol. 2006;126(10):2316-2322. (Pubitemid 44413180)
46. Bhandarkar SS, Jaconi M, Fried LE, et al. Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice. J Clin Invest. 2009;119(8):2359-2365.
47. Fulton DJ. Nox5 and the regulation of cellular function. Antioxid Redox Signal. 2009;11(10):2443-2452.